跳至主要内容
临床试验/NCT06517186
NCT06517186招募中不适用

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction (MM-HFpEF) A HeartShare Clinical Study

Northwestern University7 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2024年11月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
180
试验地点
7
主要终点
Number of participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

研究概览

简要总结

The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treatments for heart failure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HFpEF criteria
  • Age ≥30 years.
  • Left ventricular ejection fraction ≥50% measured by echocardiography, CMR or MUGA (measured within one year + clinical stability)
  • Definition of HFpEF: signs and/or symptoms of HF, NYHA functional class II-IV, and at least one of the following:
  • Elevated BNP (≥75 pg/ml in sinus rhythm or ≥225 pg/ml in atrial fibrillation/flutter) or NTproBNP (≥225 pg/ml in sinus rhythm or ≥675 in atrial fibrillation/flutter) at baseline. Choice of BNP or NTproBNP is based on availability at each clinical center.
  • Prior HF hospitalization (primary reason for the hospitalization is HF with elevated natriuretic peptide levels [using the thresholds listed above], requiring IV diuresis for HF, or pulmonary edema or pulmonary vascular congestion on chest radiography).
  • Previously documented elevated pulmonary capillary wedge pressure (PCWP) at rest (≥15 mmHg) or during exercise (≥25 mmHg for supine exercise or PCWP/cardiac output ratio ≥2 mmHg/L/min for upright exercise).
  • Elevated H2FPEF score69 (≥5) or HFA-PEFF70 score (≥5).
  • Suspected HFpEF criteria
  • Age ≥30 years.
  • Left ventricular ejection fraction ≥50% measured by echocardiography, CMR or MUGA (measured within one year + clinical stability)
  • Signs and/or symptoms of HF, NYHA functional class II-IV and all of the following:
  • Does not meet BNP or NT-proBNP criteria for HFpEF (above)
  • No prior HF hospitalization meeting HF criteria (above)
  • No previous hemodynamic catheterization documentation of HF (as above)

排除标准

  • 1. Inadequate echo or fluoroscopic images.
  • 2. Neck anatomy unfavorable for jugular venous cannulation
  • 3. Therapy with direct oral anticoagulants without cessation for a period (age, renal function, and agent specific) deemed adequate to normalize coagulation according to local clinical guidelines.
  • 4. Previous or ongoing therapy with warfarin with INR ≥ 1.6 measured day before or of EMB
  • 5. Platelet count < 50,000/ml
  • 6. Active bleeding or coagulation disorder
  • 7. Infection or fever
  • 8. Endocarditis
  • 9. Pregnancy
  • 10. Intracardiac thrombus
  • 11. RV Aneurysm
  • 12. Clinically significant tricuspid, pulmonary or aortic valve stenosis
  • 13. Tricuspid or pulmonary mechanical valve prosthesis
  • 14. Left bundle branch block

研究组 & 干预措施

HFpEF

Participants with HFpEF

Non-HFpEF

Participants without HFpEF

结局指标

主要结局

Number of participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

时间窗: Up to 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sanjiv Shah

Stone Endowed Professor of Medicine, Director of Research, Bluhm Cardiovascular Institute, Principal Investigator, HeartShare Data Translation Center

Northwestern University

研究点 (7)

Loading locations...

相似试验